MetabioMed Rises 5.04% Amid Uptrend in Dental Treatment (Implants, etc.) Theme

On the 21st, the dental treatment (including implants) theme rose by 3.13% compared to the previous day, showing strength, while MetabioMed, a related stock attracting attention, surged by 5.04% compared to the previous day. MetabioMed is known as a manufacturer and seller of dental materials.

[Graph] Price Fluctuations of Major Stocks in the Dental Treatment (Implants, etc.) Theme

According to provisional data compiled at 10:16, foreigners have purchased 78,700 shares of MetabioMed, indicating a large net buying by foreign investors.

[Table] Net Trading Volume of Foreigners and Institutions (Unit: 10,000 shares)

According to the analysis by Thinkpool RoboAlgorithm RASSI, MetabioMed’s quant financial score is 22.89 points, ranking 8th in the dental treatment (including implants) related theme. This can be interpreted as MetabioMed having relatively low investment attractiveness from a financial perspective. On the other hand, Vatech ranked 1st in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of RoboAlgorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.